← Back to Search

Point-of-care Ultrasound for Left Ventricular Hypertrophy

N/A

Recruiting

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Two blood pressure measurements greater than 140 mmHg systolic and greater than 90 mmHg diastolic on two separate vital sign checks obtained as part of routine ED care

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through the end of the study, approximately 6 months

Awards & highlights

Study Summary

This trial seeks to evaluate the effectiveness of using ultrasound to diagnose LVH in the ED and reduce disparities in diagnosis and treatment.

Who is the study for?

This trial is for Emergency Department patients with high blood pressure readings (over 140/90 mmHg) on two separate checks, who haven't been treated for hypertension or known heart enlargement in the last year and aren't currently under a cardiologist's care. It excludes those too ill to consent, admitted to the hospital, or suspected of having a hypertensive emergency.Check my eligibility

What is being tested?

The study aims to identify undiagnosed heart enlargement due to high blood pressure using point-of-care ultrasound (POCUS). Participants will receive education about their condition and expedited referrals for follow-up care. The impact on treatment rates after three months is being measured.See study design

What are the potential side effects?

Since this trial involves diagnostic procedures and customized instructions rather than medication, there are no direct side effects from interventions like drugs. However, participants may experience anxiety or discomfort during POCUS.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My blood pressure was over 140/90 mmHg in two separate checks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through the end of the study, approximately 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through the end of the study, approximately 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through the end of the study, approximately 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Prevalence of LVH by POCUS

Secondary outcome measures

Prevalence of LVH stratified by race, ethnicity and gender

Rate of successful follow-up in group of subjects with LVH on POCUS

Rate of treatment in group of subjects with LVH on POCUS

Trial Design

1Treatment groups

Experimental Treatment

Group I: Feasibility: Disclosure, customized discharge and expedited referral instructionsExperimental Treatment1 Intervention

Participants enrolled in the Aim 1 cohort with LVH on POCUS will receive the study intervention consisting of disclosure, counseling with set discharge instructions and expedited referral (communication to existing primary care physician OR referral to follow-up clinic if no existing primary care)

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,853 Previous Clinical Trials

2,738,361 Total Patients Enrolled

Media Library

Feasibility: Disclosure, customized discharge and expedited referral instructions Clinical Trial Eligibility Overview. Trial Name: NCT05730309 — N/A

Left Ventricular Hypertrophy Research Study Groups: Feasibility: Disclosure, customized discharge and expedited referral instructions

Left Ventricular Hypertrophy Clinical Trial 2023: Feasibility: Disclosure, customized discharge and expedited referral instructions Highlights & Side Effects. Trial Name: NCT05730309 — N/A

Feasibility: Disclosure, customized discharge and expedited referral instructions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05730309 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities to join this clinical experiment presently available?

"According to the clinicaltrials.gov database, this particular medical trial is presently not seeking out participants as it was last edited on February 6th 2023. Though inactive at present, there are 86 other studies currently in recruitment phase."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

2023. "Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05730309.

All > Hypertrophy